DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 91 filers reported holding DEXCOM INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,632,000 | +45766.7% | 9,632,000 | +50594.7% | 0.00% | – |
| Q1 2024 | $21,000 | +200.0% | 19,000 | +171.4% | 0.00% | – |
| Q4 2023 | $7,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q3 2023 | $7,000 | 0.0% | 7,000 | 0.0% | 0.00% | – |
| Q2 2023 | $7,000 | -99.9% | 7,000 | -99.9% | 0.00% | -100.0% |
| Q1 2023 | $6,733,000 | -26.2% | 6,262,000 | -25.4% | 0.00% | -33.3% |
| Q4 2022 | $9,128,000 | +75966.7% | 8,393,000 | +64461.5% | 0.00% | – |
| Q3 2022 | $12,000 | -99.8% | 13,000 | -99.7% | 0.00% | -100.0% |
| Q1 2022 | $5,424,000 | -42.3% | 4,750,000 | -40.0% | 0.00% | -50.0% |
| Q4 2021 | $9,402,000 | -18.4% | 7,918,000 | -18.5% | 0.00% | -33.3% |
| Q3 2021 | $11,527,000 | +9.6% | 9,718,000 | -3.5% | 0.00% | 0.0% |
| Q2 2021 | $10,515,000 | – | 10,068,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PIER 88 INVESTMENT PARTNERS LLC | 17,495,000 | $16,120,000 | 3.83% |
| SSI INVESTMENT MANAGEMENT LLC | 34,177,000 | $31,482,000 | 2.11% |
| Liberty Mutual Group Asset Management Inc. | 4,075,000 | $3,754,000 | 1.13% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 64,568,000 | $59,806,000 | 1.08% |
| MACKAY SHIELDS LLC | 43,555,000 | $40,304,000 | 1.02% |
| SHENKMAN CAPITAL MANAGEMENT INC | 18,523,000 | $17,071,000 | 0.96% |
| ZAZOVE ASSOCIATES LLC | 9,022,000 | $8,360,000 | 0.76% |
| Calamos Advisors LLC | 66,187,000 | $61,330,000 | 0.28% |
| RWC Asset Management LLP | 6,000,000 | $5,566,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 6,219,000 | $5,766,000 | 0.16% |